Global at-home vaginal ph test kit demand is anticipated to be valued at US$ 100 Million in 2022, forecast to grow at a CAGR of 5.76% to be valued at US$ 175 Million from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2021) | US$ 95 Million |
| Expected Market Value (2022) | US$ 100 Million |
| Anticipated Forecast Value (2032) | US$ 175 Million |
| Projected Growth Rate (2022 to 2032) | 5.76% CAGR |
The pH of vaginal secretion is measured using at-home vaginal pH test kits. The At-Home Vaginal pH Test is a qualitative test used to determine an unbalanced pH level of vaginal secretion. In the case of unusual vaginal symptoms such as unpleasant odor, burning, itching, or unusual discharge, an at-home vaginal pH test is performed.
At-home vaginal pH tests can help determine whether a patient is experiencing unusual vaginal symptoms. The at-home vaginal pH test, on the other hand, will not aid in the diagnosis of group B streptococcus HIV, gonorrhea, herpes, syphilis, or Chlamydia.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The At-Home Vaginal pH Test detects vaginal infections early. The pH of the vaginal fluid should be between 3.8 and 4.5. If a vaginal pH of 5.0 or higher is detected using at-home vaginal pH test kits, it indicates the presence of either trichomoniasis or bacterial vaginosis.
A pH less than 3.5, on the other hand, indicates the presence of yeast infection. Furthermore, at-home vaginal pH test kits are a cost-effective option for detecting vaginitis at home without visiting a doctor. Furthermore, the at-home vaginal pH test kit is useful for maintaining the pH balance of the vaginal area, early diagnosis of the disorder related to vaginal flora, prevention of vaginal infection, greater safety during pregnancy, and monitoring the effectiveness of any treatment. These factors and benefits are expected to drive the market for at-home vaginal pH test kits forward.
If the woman has recently had intercourse or is on her period, the results of at-home vaginal pH test kits may be inaccurate. Even after using an at-home vaginal pH test, most patients should still see a doctor or a gynecologist to get the most accurate diagnosis. These factors are expected to have a negative impact on the growth of the market for at-home vaginal pH test kits.
Principal Consultant
Asia Pacific is expected to be the largest market for At-Home Vaginal pH Test Kit during the forecast period owing to increasing awareness about vaginal infections as well as hygiene among the women in this region. The growing practice of self-testing is expected to augment the At-Home Vaginal pH Test Kit market. The region is forecast to surge in the upcoming years.
According to Future Market Insights, Europe is expected to provide immense growth opportunities for the At-Home Vaginal pH Test Kit, with Germany expected to steer the bulk of all regional growth. Extensive applications in the pharmaceutical industry are keeping sales of At-Home Vaginal pH Test Kit afloat across Germany.
Countries such as Poland, Belgium, the United Kingdom, and the Czech Republic are all also generating high demand for At-Home Vaginal pH Test Kit, as these regions are witnessing an increasing awareness of vaginal hygiene.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Home test, Bayer AG, Prestige Consumer Healthcare, Inc., GRÜNSPECHT Naturprodukte GmbH, Vagisil, and Dream Future Innovation are some of the market participants identified across the value chain in the Global At-Home Vaginal pH Test kit market.
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 5.76% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2015 to 2020 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million, Volume in Kilotons, and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
FMI projects the global At-Home Vaginal pH Test Kit market to expand at a 5.76% value CAGR by 2032.
Asia Pacific is expected to be the most opportunistic At-Home Vaginal pH Test Kit market.
Home test, Bayer AG, Prestige Consumer Healthcare, Inc, and Dream Future Innovation are some prominent At-Home Vaginal pH Test Kit manufacturers.
1. Executive Summary | At-Home Vaginal pH Test Kit Market
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. Value Chain Analysis
3.5.1. Profit Margin Analysis
3.5.2. Service Providers
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ Million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Indication
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) Analysis By Indication, 2017 to 2021
5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Indication, 2022 to 2032
5.3.1. Trichomoniasis
5.3.2. Bacterial Vaginosis
5.3.3. Yeast Infection
5.3.4. Others
5.4. Y-o-Y Growth Trend Analysis By Indication, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Indication, 2022 to 2032 Deep-dive segmentation will be available in the sample on request
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) Analysis By Distribution Channel, 2017 to 2021
6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Distribution Channel, 2022 to 2032
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Online Pharmacies
6.3.4. Fertilization Centers
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2021
7.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2022 to 2032
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. East Asia
7.3.5. South Asia & Pacific
7.3.6. Middle East and Africa
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
8.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
8.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
8.2.1. By Country
8.2.1.1. USA
8.2.1.2. Canada
8.2.2. By Indication
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Indication
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. Mexico
9.2.1.2. Brazil
9.2.1.3. Rest of Latin America
9.2.2. By Indication
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Indication
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. Italy
10.2.1.3. France
10.2.1.4. United Kingdom
10.2.1.5. Spain
10.2.1.6. BENELUX
10.2.1.7. Russia
10.2.1.8. Rest of Europe
10.2.2. By Indication
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Indication
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.2. By Indication
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Indication
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. South Asia & Pacific Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. ASEAN
12.2.1.3. Australia and New Zealand
12.2.1.4. Rest of South Asia & Pacific
12.2.2. By Indication
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Indication
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. Middle East and Africa Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. Turkey
13.2.1.3. South Africa
13.2.1.4. Rest of Middle East and Africa
13.2.2. By Indication
13.2.3. By Distribution Channel
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Indication
13.3.3. By Distribution Channel
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2021
14.1.2.1. By Indication
14.1.2.2. By Distribution Channel
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2021
14.2.2.1. By Indication
14.2.2.2. By Distribution Channel
14.3. Mexico
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2021
14.3.2.1. By Indication
14.3.2.2. By Distribution Channel
14.4. Brazil
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2021
14.4.2.1. By Indication
14.4.2.2. By Distribution Channel
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2021
14.5.2.1. By Indication
14.5.2.2. By Distribution Channel
14.6. Italy
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2021
14.6.2.1. By Indication
14.6.2.2. By Distribution Channel
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2021
14.7.2.1. By Indication
14.7.2.2. By Distribution Channel
14.8. United Kingdom
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2021
14.8.2.1. By Indication
14.8.2.2. By Distribution Channel
14.9. Spain
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2021
14.9.2.1. By Indication
14.9.2.2. By Distribution Channel
14.10. BENELUX
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2021
14.10.2.1. By Indication
14.10.2.2. By Distribution Channel
14.11. Russia
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2021
14.11.2.1. By Indication
14.11.2.2. By Distribution Channel
14.12. China
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2021
14.12.2.1. By Indication
14.12.2.2. By Distribution Channel
14.13. Japan
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2021
14.13.2.1. By Indication
14.13.2.2. By Distribution Channel
14.14. South Korea
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2021
14.14.2.1. By Indication
14.14.2.2. By Distribution Channel
14.15. India
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2021
14.15.2.1. By Indication
14.15.2.2. By Distribution Channel
14.16. ASIAN
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2021
14.16.2.1. By Indication
14.16.2.2. By Distribution Channel
14.17. Australia and New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2021
14.17.2.1. By Indication
14.17.2.2. By Distribution Channel
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2021
14.18.2.1. By Indication
14.18.2.2. By Distribution Channel
14.19. Turkey
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2021
14.19.2.1. By Indication
14.19.2.2. By Distribution Channel
14.20. South Africa
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2021
14.20.2.1. By Indication
14.20.2.2. By Distribution Channel
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Indication
15.3.3. By Distribution Channel
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Bayer AG
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Hometest
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Prestige Consumer Healthcare, Inc.
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Vagisil
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. AdvaCare
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. Pee Safe
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. GRÜNSPECHT Naturprodukte GmbH
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Savyon Diagnostics
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. Sanotest
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. AAA Surgical Pharma
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Setia Scientific Solution
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
At-Home Vaginal pH Test Kit Market
